STERIS plc provides infection prevention and other procedural products and services worldwide. It operates in four segments: Healthcare Products, Healthcare Specialty Services, Life Sciences, and Applied Sterilization Technologies. The Healthcare Products segment offers cleaning chemistries and sterility assurance products; accessories for gastrointestinal (GI) procedures, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, equipment management services, and connectivity solutions. It also provides capital equipment installation, maintenance, upgradation, repair, and troubleshooting services. This segment offers its products and services to acute care hospitals, ambulatory surgery centers, and GI clinics. The Healthcare Specialty Services segment provides solutions and managed services, such as instrument and endoscope repair and maintenance solutions; custom process improvement consulting services; and outsourced instrument sterile processing services to acute care hospitals and other healthcare settings. The Life Sciences segment offers formulated cleaning chemistries, barrier products, sterility assurance products, steam and vaporized hydrogen peroxide sterilizers, and washer disinfectors. The Applied Sterilization Technologies segment provides contract sterilization services through a network of approximately 50 contract sterilization and laboratory facilities.The company was founded on December 22, 2016 and is headquartered in Dublin, Ireland.
Highlights
The company's net income rose by 29% YoY
The company's EPS rose by 29% YoY
STE's P/E is 9% above its last 4 quarters average of 32.5 but 8% below its 5-year quarterly average of 38.4
STERIS's quick ratio has decreased by 12% from the previous quarter and by 9% YoY
Key stats
What are the main financial stats of STE
Market
Shares outstanding
85.05M
Market cap
$14.59B
Enterprise value
$15.53B
Valuations
Price to earnings (P/E)
35.29
Price to book (P/B)
4.19
Price to sales (P/S)
4.85
EV/EBIT
28.48
EV/EBITDA
20.86
EV/Sales
5.17
Earnings
Revenue
$3B
EBIT
$545.45M
EBITDA
$744.54M
Free cash flow
$388.04M
Per share
EPS
$4.86
Free cash flow per share
$4.57
Book value per share
$40.92
Revenue per share
$35.36
TBVPS
$28.74
Balance sheet
Total assets
$5.36B
Total liabilities
$1.87B
Debt
$1.2B
Equity
$3.47B
Working capital
$617.58M
Liquidity
Debt to equity
0.35
Current ratio
2.29
Quick ratio
1.58
Net debt/EBITDA
1.27
Margins
EBITDA margin
24.8%
Gross margin
43.3%
Net margin
13.7%
Operating margin
18%
Efficiency
Return on assets
7.7%
Return on equity
12.2%
Return on invested capital
18.5%
Return on capital employed
11.2%
Return on sales
18.2%
Dividend
Dividend yield
0.88%
DPS
$1.51
Payout ratio
31.1%
STE stock price
How has the STERIS stock price performed over time
Financial performance
How have STERIS's revenue and profit performed over time
Revenue
$3B
Gross profit
$1.3B
Operating income
$540.89M
Net income
$411.21M
Gross margin
43.3%
Net margin
13.7%
The company's net income rose by 29% YoY
STE's operating income is up by 27% YoY
STERIS's net margin has increased by 22% YoY and by 2.2% from the previous quarter
STE's operating margin is up by 20% year-on-year
Growth
What is STERIS's growth rate over time
Valuation
What is STERIS stock price valuation
P/E
35.29
P/B
4.19
P/S
4.85
EV/EBIT
28.48
EV/EBITDA
20.86
EV/Sales
5.17
The company's EPS rose by 29% YoY
STE's P/E is 9% above its last 4 quarters average of 32.5 but 8% below its 5-year quarterly average of 38.4
STE's P/B is 50% above its 5-year quarterly average of 2.8 and 13% above its last 4 quarters average of 3.7
The company's equity rose by 7% YoY and by 2.4% QoQ
The P/S is 47% above the 5-year quarterly average of 3.3 and 16% above the last 4 quarters average of 4.2
The revenue has grown by 6% YoY
Efficiency
How efficient is STERIS business performance
STERIS's ROA has increased by 22% YoY
The ROE has increased by 21% YoY
The company's return on sales rose by 21% YoY and by 2.2% QoQ
STERIS's ROIC has increased by 19% YoY
Dividends
What is STE's dividend history
DPS
$1.51
Dividend yield
0.88%
Payout ratio
31.1%
Recent dividends
Financial health
How did STERIS financials performed over time
The total assets is 186% more than the total liabilities
STERIS's quick ratio has decreased by 12% from the previous quarter and by 9% YoY
STE's total liabilities is down by 7% since the previous quarter and by 6% year-on-year
STERIS's debt is 65% less than its equity
STE's debt to equity is down by 15% year-on-year and by 8% since the previous quarter
STERIS's debt has decreased by 10% YoY and by 6% from the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated
quarterly, unless otherwise specified.